Loading clinical trials...
Loading clinical trials...
Feeding Tolerance and Growth of Preterm Infants Consuming a Supplement Containing Two Human Milk Oligosaccharides (HMOs): A Post-Market Study
Conditions
Interventions
HMO supplement
Locations
6
Austria
Kepler Universitätsklinikum Linz
Linz, Austria
Evangelisches Waldkrankenhaus Spandau
Berlin-Spandau, Germany
Kinderklinik Darmstadt
Darmstadt, Germany
Wilhelmstift Hamburg
Hamburg, Germany
Uniklinik Heidelberg
Heidelberg, Germany
Klinikum Nürnberg
Nuremberg, Germany
Start Date
November 20, 2023
Primary Completion Date
February 28, 2026
Completion Date
February 28, 2026
Last Updated
December 8, 2025
NCT07344714
NCT07060573
NCT07410858
NCT07349251
NCT07322731
NCT07254000
Lead Sponsor
Société des Produits Nestlé (SPN)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions